South San Francisco, CA
Principia Biopharma Inc. operates as a clinical stage biopharmaceutical company. The Company offers reversible covalent small molecule drugs for the treatment of cancers. Principia Biopharma serves patients in the United States.
principiabio.comThese are collections Principia Biopharma is a part of. Click on the collection name to view similar companies.
Post Ipo Equity
$210,000,000
Series Unknown
$49,999,978
IPO
Unknown
Series B
$15,300,000
Series B
$50,000,000
Series A
$12,500,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Principia Biopharma.